ESROLAS

Serial Number 99089165
602

Registration Progress

Application Filed
Mar 18, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Abandonment Notice E-Mailed - Failure to Respond
Due: Mar 11, 2026 38 days
Revival assistance for abandoned trademark

Trademark Image

ESROLAS

Basic Information

Serial Number
99089165
Filing Date
March 18, 2025
Abandonment Date
November 19, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jan 11, 2026
Classes
005

Rights Holder

Sermonix Pharmaceuticals, Inc.

03
Address
250 East Broad Street, Suite 250
Columbus, OH 43215

Ownership History

Sermonix Pharmaceuticals, Inc.

Original Applicant
03
Columbus, OH

Legal Representation

Attorney
Karen A. Webb

USPTO Deadlines

Next Deadline
38 days remaining
Abandonment Notice E-Mailed - Failure to Respond
Due Date
March 11, 2026

Application History

9 events
Date Code Type Description Documents
Jan 11, 2026 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jan 11, 2026 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 18, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 18, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 18, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 18, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 18, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 18, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 18, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of breast cancer

Classification

International Classes
005